Navigation Links
NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
Date:1/12/2009

ans with regard to seeking potential development partners for its early-stage product pipeline. Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to, NeurogesX' product candidates may have unexpected adverse side effects or inadequate therapeutic efficacy; positive results in clinical trials may not be sufficient to obtain FDA or European regulatory approval; any regulatory approvals which are received may offer more limited indications than anticipated; physician or patient reluctance to use Qutenza or NGX-1998, if approved, or the inability of physicians to obtain sufficient reimbursement for such procedures; potential alternative therapies; maintaining adequate patent or trade secret protection without violating the intellectual property rights of others; and other difficulties or delays in, clinical development, obtaining regulatory approval, market acceptance and commercialization of NeurogesX' product candidates and the advantages of NeurogesX' product candidates over other pain therapies. For further information regarding these and other risks related to NeurogesX' business, investors should consult NeurogesX' filings with the Securities and Exchange Commission.

    NeurogesX, Inc.
    Stephen Ghiglieri
    Chief Financial Officer
    (650) 358-3310

    The Ruth Group
    Stephanie Carrington / Sara Ephraim (investors)
    (646) 536-7017 / 7002
    scarrington@theruthgroup.com
    sephraim@theruthgroup.com

    Jason Rando (media)
    (646) 536-7025
    jrando@theruthgroup.com


'/>"/>
SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
2. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
3. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
4. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
5. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
6. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
7. Pulmo BioTech Inc. Announces Dual Listing on Frankfurt Borse
8. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
9. Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication
10. ProUroCare Medical Inc. Announces Pricing of Equity Offering
11. Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 2015  Researchers at the Blanchette Rockefeller Neurosciences ... Edwards School of Medicine announced their findings from ... Family with Atypical AD."  An Alzheimer patient with ... known variant of PSEN1, showed promising benefits during ... Alzheimer,s patients as severely advanced as patient IV-18 ...
(Date:3/30/2015)... March 30, 2015  The investigational S- equol ... certain menopause symptoms, such as hot flashes, according to ... of Women,s Health .[i] "Current data suggest ... for menopausal vasomotor symptoms and possibly additional benefits, such ... S- equol, physicians and health care professionals may ...
(Date:3/30/2015)... N.Y., March 30, 2015  Uroplasty, Inc. (NASDAQ: ... ) shareholders have voted at the special meeting ... the previously announced agreement and plan of merger ... pleased with the outcome of today,s special meetings, ... groups for approving the merger agreement," said ...
Breaking Medicine Technology:Severe Alzheimer's Patient Responds to Bryostatin Treatment 2Severe Alzheimer's Patient Responds to Bryostatin Treatment 3Severe Alzheimer's Patient Responds to Bryostatin Treatment 4Severe Alzheimer's Patient Responds to Bryostatin Treatment 5New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 2New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 3New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 4New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 5New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 6Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 2Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 4
... 2011 Watson Pharmaceuticals, Inc. (NYSE: WPI ), ... Company intends to release its second quarter 2011 financial results ... the U.S. financial markets.  The Company will also host a ... July 26, 2011 to discuss its financial results and provide ...
... BRUSSELS, June 30, 2011 UCB and Harvard University ... ceremony that took place in Boston last night in ... Belgium. (Photo: http://photos.prnewswire.com/prnh/20110630/NY28450 ) ... between industry and academia, with Harvard scientists continuing their ...
Cached Medicine Technology:Watson to Host Conference Call and Webcast to Discuss Second Quarter 2011 Earnings 2UCB Launches Research Alliance with Harvard University 2UCB Launches Research Alliance with Harvard University 3
(Date:3/31/2015)... MO (PRWEB) March 31, 2015 ... University maternal-fetal medicine specialists at Barnes-Jewish Hospital to ... of the Southern Illinois Healthcare (SIH) system. , ... area needed a maternal-fetal medicine consultation, she had ... get an ultrasound and then talk with a ...
(Date:3/30/2015)... Wireless Analytics, LLC , a pioneering provider ... one of the Boston Business Journal’s 2015 Pacesetters ... Massachusetts. The list represents 70 privately held businesses ... through 2014. 2015 marks the second year in ... Analytics’s revenue growth. The Danvers-based managed mobility service ...
(Date:3/30/2015)... 2015 Phoenix Strategic Performance, a human ... launch of the PSP Institute. The Institute develops ... development with a direct connection to applied business results. ... work of the Phoenix Strategic Performance Assessment and Alignment ... is in an organization’s ability to take an honest ...
(Date:3/30/2015)... 31, 2015 Thomas Peither and ... respected inspection readiness professionals — will conduct a ... the inspection process. , Attendees will learn exactly ... and what they look for when conducting an ... and roundtable discussions. This will assure attendees are ...
(Date:3/30/2015)... (PRWEB) March 31, 2015 NAPW ... 2015 Professional Woman of the Year. Ms. Lucht is ... As the largest, most-recognized networking organization of professional women ... the National Association of Professional Women is a powerfully ... 200 Local Chapters. , “Today’s managers need to have ...
Breaking Medicine News(10 mins):Health News:Access to Maternal-fetal Experts Expands into Rural Communities 2Health News:Access to Maternal-fetal Experts Expands into Rural Communities 3Health News:Wireless Analytics Growth Streak Continues; Named to Boston Business Journal’s Pacesetters Second Year In a Row 2Health News:Wireless Analytics Growth Streak Continues; Named to Boston Business Journal’s Pacesetters Second Year In a Row 3Health News:Phoenix Strategic Performance Launches Human Capital Development Institute 2Health News:Phoenix Strategic Performance Launches Human Capital Development Institute 3Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 2Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 3Health News:FDAnews Announces — GMP Inspections in Europe: Proven Strategies on How to Prepare Investigations, June 10-11, 2015, Frankfurt, Germany 4Health News:National Association of Professional Women Announces Winifred K. Lucht, Patient Financial Services Manager at Marshfield Clinic, a 2015 Professional Woman of the Year 2
... National Committee for Quality Assurance Certifies Quality of Health ... ... 8 AMERIGROUP Community Care of,Georgia announced today that it has ... Assurance (NCQA),certifying that it offers high-quality services to its 218,000 members., ...
... Fairview Specialty Pharmacy today,announced that it has been ... pharmacy in the specialty pharmacy limited distribution,network for ... approved for the treatment of phenylketonuria (PKU)., ... Drug Administration (FDA) on,December 13 and is now ...
... Round Table Family,Charities raised $350,000 for Children,s Miracle ... the United States. This is the,second consecutive year ... CMN and the cause of helping children., ... Family Charities,Second Annual Golf Tournament. The event, held ...
... 8 The American Red Cross,announced today that ... position of,Executive Vice President for the organization,s Biomedical ... nation,s largest blood collection,organizations. Each year the American ... and distributes around 9.5 million blood products to,patients ...
... Technology and "Paperless" Environment ... Make it Among the First of Its Kind, ... Methodist Hospital this morning at 7 a.m. sharp to begin ... Ohio.,Dublin Methodist, the first new, full-service hospital to be built ...
... by the American Association for Homecare, ARLINGTON, Va., ... supports efforts to crack down on,Medicare fraud announced today ... the Centers for Medicare and Medicaid Services (CMS) on ... agencies and,Congress to prevent fraudulent activity in the durable ...
Cached Medicine News:Health News:AMERIGROUP Community Care of Georgia Wins New Health Plan Accreditation from NCQA 2Health News:Fairview Specialty Pharmacy Signs Contract With BioMarin for Distribution of Kuvan(TM) 2Health News:Fairview Specialty Pharmacy Signs Contract With BioMarin for Distribution of Kuvan(TM) 3Health News:Round Table Family Charities Raises $350,000 for Children's Miracle Network 2Health News:American Red Cross Announces New Leader for Biomedical Services 2Health News:OhioHealth Opens Doors to Next Generation Hospital 2Health News:OhioHealth Opens Doors to Next Generation Hospital 3Health News:OhioHealth Opens Doors to Next Generation Hospital 4Health News:OhioHealth Opens Doors to Next Generation Hospital 5Health News:Medicare Anti-Fraud Measures are Way Overdue, Says Durable Medical Equipment Industry 2Health News:Medicare Anti-Fraud Measures are Way Overdue, Says Durable Medical Equipment Industry 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: